Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2020 Dec 17;106(5):1457–1460. doi: 10.3324/haematol.2020.269878

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2021 Ferrata Storti Foundation

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

PMC Copyright notice

Figure 1. — Immune response in COVID-19 patients and hematological cancer patients. (A) Schematic representation of semi-automated analysis of flow cytometric data and clustering of 17 immune cell types systematically identified in a total of 513 patients diagnosed with coronavirus disease 2019 (COVID-19). (B) Relative distribution of immune cell types in COVID-19 patients with (n=10, dots) and without (n=503, boxes) blood cancer. (C) Ratio between the percentage of each immune cell type at last follow-up and presentation in COVID-19 patients with (n=6, dots) and without (n=161, line) hematological tumor. Blue dots indicate alive patients and red dots represent deceased patients. Dashed line represents no variation over time (ratio = 1).*P<0.05; **, P<0.01; ***P<0.001. PC: plasma cells. : NK: natural killer cells.